List of Tables
Table 1. Global CAR T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of CD19 - Targeted
Table 3. Major Companies of BCMA - Targeted
Table 4. Global CAR T-Cell Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global CAR T-Cell Therapy Market Size by Region (US$ Million): 2022 VS 2028
Table 6. Global CAR T-Cell Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global CAR T-Cell Therapy Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 8. CAR T-Cell Therapy Revenue by Company (2017-2022) & (US$ Million)
Table 9. CAR T-Cell Therapy Revenue Share by Company (2017-2022)
Table 10. Ranking of Global Top CAR T-Cell Therapy Players by Revenue (US$ Million) in 2021
Table 11. Global CAR T-Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 12. Global CAR T-Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021)
Table 13. Global CAR T-Cell Therapy Companies Headquarters
Table 14. Global CAR T-Cell Therapy Companies Product & Service
Table 15. Date of International Companies Enter into CAR T-Cell Therapy Market
Table 16. Global CAR T-Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 17. Novartis Corporation Information
Table 18. Novartis Description and Business Overview
Table 19. Novartis CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 20. Novartis CAR T-Cell Therapy Product
Table 21. Novartis CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 22. Novartis CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 23. Novartis CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 24. Novartis Recent Development
Table 25. Gilead Sciences Corporation Information
Table 26. Gilead Sciences Description and Business Overview
Table 27. Gilead Sciences CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 28. Gilead Sciences CAR T-Cell Therapy Product
Table 29. Gilead Sciences CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 30. Gilead Sciences CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 31. Gilead Sciences CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 32. Gilead Sciences Recent Development
Table 33. Bristol-Myers Squibb Corporation Information
Table 34. Bristol-Myers Squibb Description and Business Overview
Table 35. Bristol-Myers Squibb CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 36. Bristol-Myers Squibb CAR T-Cell Therapy Product
Table 37. Bristol-Myers Squibb CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 38. Bristol-Myers Squibb CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 39. Bristol-Myers Squibb CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 40. Bristol-Myers Squibb Recent Development
Table 41. J & J Corporation Information
Table 42. J & J Description and Business Overview
Table 43. J & J CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 44. J & J CAR T-Cell Therapy Product
Table 45. J & J CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 46. J & J CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 47. J & J CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 48. J & J Recent Development
Table 49. JW Therapeutics Corporation Information
Table 50. JW Therapeutics Description and Business Overview
Table 51. JW Therapeutics CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 52. JW Therapeutics CAR T-Cell Therapy Product
Table 53. JW Therapeutics CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 54. JW Therapeutics CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 55. JW Therapeutics CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 56. JW Therapeutics Recent Development
Table 57. FOSUNKite Corporation Information
Table 58. FOSUNKite Description and Business Overview
Table 59. FOSUNKite CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 60. FOSUNKite CAR T-Cell Therapy Product
Table 61. FOSUNKite CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 62. FOSUNKite CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 63. FOSUNKite CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 64. CARsgen Therapeutics (Pipeline) Corporation Information
Table 65. CARsgen Therapeutics (Pipeline) Description and Business Overview
Table 66. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 67. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product
Table 68. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 69. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 70. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 71. Autolus Therapeutics(Pipeline) Corporation Information
Table 72. Autolus Therapeutics(Pipeline) Description and Business Overview
Table 73. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 74. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product
Table 75. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 76. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 77. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 78. Sorrento Therapeutics(Pipeline) Corporation Information
Table 79. Sorrento Therapeutics(Pipeline) Description and Business Overview
Table 80. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 81. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product
Table 82. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 83. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 84. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 85. Mustang Bio(Pipeline) Corporation Information
Table 86. Mustang Bio(Pipeline) Description and Business Overview
Table 87. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 88. Mustang Bio(Pipeline) CAR T-Cell Therapy Product
Table 89. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 90. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 91. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 92. Bluebird Bio(Pipeline) Corporation Information
Table 93. Bluebird Bio(Pipeline) Description and Business Overview
Table 94. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 95. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product
Table 96. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 97. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 98. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 99. Cellectis(Pipeline) Corporation Information
Table 100. Cellectis(Pipeline) Description and Business Overview
Table 101. Cellectis(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 102. Cellectis(Pipeline) CAR T-Cell Therapy Product
Table 103. Cellectis(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 104. Cellectis(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 105. Cellectis(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 106. Allogene Therapeutics(Pipeline) Corporation Information
Table 107. Allogene Therapeutics(Pipeline) Description and Business Overview
Table 108. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 109. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product
Table 110. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 111. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 112. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 113. Celyad(Pipeline) Corporation Information
Table 114. Celyad(Pipeline) Description and Business Overview
Table 115. Celyad(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
Table 116. Celyad(Pipeline) CAR T-Cell Therapy Product
Table 117. Celyad(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Product in 2021
Table 118. Celyad(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Application in 2021
Table 119. Celyad(Pipeline) CAR T-Cell Therapy Revenue Proportion of CAR T-Cell Therapy by Geographic Area in 2021
Table 120. Global CAR T-Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 121. Global CAR T-Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 122. Global CAR T-Cell Therapy Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 123. North America CAR T-Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 124. North America CAR T-Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 125. North America CAR T-Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 126. North America CAR T-Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 127. Asia-Pacific CAR T-Cell Therapy Revenue by Region (2017-2028) & (US$ Million)
Table 128. Asia-Pacific CAR T-Cell Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 129. Asia-Pacific CAR T-Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 130. Asia-Pacific CAR T-Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 131. Europe CAR T-Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 132. Europe CAR T-Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 133. Europe CAR T-Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 134. Europe CAR T-Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 135. Latin America CAR T-Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 136. Latin America CAR T-Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 137. Latin America CAR T-Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 138. Latin America CAR T-Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 139. Middle East and Africa CAR T-Cell Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 140. Middle East and Africa CAR T-Cell Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 141. Middle East and Africa CAR T-Cell Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 142. Middle East and Africa CAR T-Cell Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 143. CAR T-Cell Therapy Key Raw Materials, Industry Status and Trend
Table 144. CAR T-Cell Therapy Key Raw Materials and Upstream Suppliers
Table 145. CAR T-Cell Therapy Clients Status and Trend
Table 146. CAR T-Cell Therapy Typical Clients
Table 147. CAR T-Cell Therapy Distributors
Table 148. CAR T-Cell Therapy Market Trends
Table 149. CAR T-Cell Therapy Market Drivers
Table 150. CAR T-Cell Therapy Market Challenges
Table 151. CAR T-Cell Therapy Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. CAR T-Cell Therapy Product Picture
Figure 2. Global CAR T-Cell Therapy Revenue Market Share by Type in 2021 & 2028
Figure 3. CD19 - Targeted Product Picture
Figure 4. BCMA - Targeted Product Picture
Figure 5. Global CAR T-Cell Therapy Revenue Market Share by Application in 2021 & 2028
Figure 6. Lymphoma
Figure 7. Multiple Myeloma
Figure 8. CAR T-Cell Therapy Report Years Considered
Figure 9. Global CAR T-Cell Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global CAR T-Cell Therapy Market Size 2017-2028 (US$ Million)
Figure 11. Global CAR T-Cell Therapy Market Size Market Share by Region: 2022 Versus 2028
Figure 12. Global CAR T-Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 13. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global CAR T-Cell Therapy Revenue Market Share Forecast by Type (2017-2028)
Figure 15. Global CAR T-Cell Therapy Revenue Market Share Forecast by Application (2017-2028)
Figure 16. North America CAR T-Cell Therapy Revenue 2017-2028 (US$ Million)
Figure 17. North America CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 18. North America CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 19. Asia-Pacific CAR T-Cell Therapy Revenue 2017-2028 (US$ Million)
Figure 20. Asia-Pacific CAR T-Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 21. Asia-Pacific CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 22. Asia-Pacific CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 23. Europe CAR T-Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 24. Europe CAR T-Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 25. Europe CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 26. Europe CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 27. Latin America CAR T-Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 28. Latin America CAR T-Cell Therapy Revenue Market Share by Country (2017-2022)
Figure 29. Latin America CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 30. Latin America CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 31. Middle East and Africa CAR T-Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 32. Middle East and Africa CAR T-Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 33. Middle East and Africa CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)
Figure 34. Middle East and Africa CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
Figure 35. CAR T-Cell Therapy Supply Chain (Upstream and Downstream Market)
Figure 36. Global Production Market Share of CAR T-Cell Therapy Raw Materials by Region in 2021
Figure 37. CAR T-Cell Therapy Distribution Channels
Figure 38. Global CAR T-Cell Therapy Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 39. Global CAR T-Cell Therapy Percentage 2017-2028: Online Sales VS Offline Sales
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
